aTYR PHARMA INC (ATYR) Latest Filing Signal
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for aTYR PHARMA INC?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, aTYR PHARMA INC's filing signal
turned negative.
earningsVibe SuperAnalyst™ Verdict:
TURNED NEGATIVE
Signal Performance — Stock Price Since Filing
30-Day Change
-8.65%
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Continuing Negative
GEMINI
Turned Negative
CLAUDE
Turned Negative
CHATGPT
Continuing Negative
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does aTYR PHARMA INC actually do?
Answer:
aTyr Pharma is a clinical-stage biotechnology company focused on developing novel therapies for fibrosis and inflammation by leveraging evolutionary intelligence to translate tRNA synthetase biology. Its lead candidate, efzofitimod, is an immunomodulator being investigated for interstitial lung diseases (ILDs) like pulmonary sarcoidosis and systemic sclerosis-associated ILD (SSc-ILD). Efzofitimod selectively modulates activated myeloid cells via neuropilin-2 to resolve inflammation without immune suppression, potentially preventing fibrosis. The company is also advancing other tRNA synthetase-derived candidates, ATYR0101 and ATYR0750, into preclinical development for fibrotic diseases. aTyr Pharma operates in a single accounting segment and is transitioning from a clinical-stage biotech to a commercial pharmaceutical company.
Question:
What are aTYR PHARMA INC's revenue drivers?
Answer:
Revenue is primarily driven by collaboration and license agreement revenues, specifically from product material sales to partners like Kyorin Pharmaceutical Co., Ltd. for development activities in Japan.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required